Home    Help    Cart    Login
Get Free Updates on Industry Research and Analysis!


Search all reports:
 Go 


Pharma and Biotech News


Marketing Services
Interested in marketing your information product through us? Email us at helpdesk AT pharma-reports.com

or call 800-304-0345




Topic Suggestion?


 Item Detail
Item Detail
You're Here: Medical » Health Care



Heart Failure: When Drugs Do Not Work - Definitions, Diagnostic Methods and Treatment Approaches

Select Your Format:
Price: $3,800.00
Shipping: US:  $100.00 
Non-US  $100.00
QTY:
Print Order form to pay by check
Heart Failure - When Drugs Do Not Work: Stakeholder Opinions
Heart Failure - When Drugs Do Not Work: Stakeholder Opinions
Datamonitor

Advanced heart failure is a growing issue. Existing pharmacological strategies increase the survival rates of acute heart failure patients, providing a growing source of patients with advanced disease. In view of long waiting lists for heart transplantation and the growing lack of donors, cardiac resynchronization and mechanical circulatory support devices have demonstrated promising results.

Scope:

- What are the current definitions, diagnostic methods and treatment approaches of the early stages of the disease?

- What are the main issues surrounding treatment approaches in the advanced stages of the disease?

- What is the current role of cardiac resynchronization therapy in treatment of advanced heart failure?

- What are the main non-pharmacological options as alternatives to heart transplantation in advanced heart failure?


Report Highlights:

- With no new drug therapies addressing advanced heart failure and existing pharmacological strategies failing to compensate a weakening heart, alternative, non-pharmacological solutions have to be found. In view of long waiting lists for heart transplantation and the growing shortage of donor hearts, the focus of treatment must shift onto devices.

- Ventricular dyssynchrony is a well recognized problem in advanced stages of heart failure. Clinical trials investigating ventricular dyssynchrony cardiac resynchronization have demonstrated promising results. However, this technology provides only temporary, symptomatic relief and neither cures nor fully stops the progression of the disease.

- In light of the growing shortage of donor hearts and failing pharmacological strategies, an artificial mechanical heart has been a long sought-after technology. Although the developments started decades ago, a fully implantable total artificial heart is still at the concept stage, with many years of research and development yet to come.


Reasons to Purchase:

- Understand current definitions, diagnostic methods and treatment approaches in advanced heart failure

- Current dynamics and future trends of the technology developments treating advanced heart failure

- Major technological and industry issues surrounding technological progress and new product development



Table of Contents



146 pages

Publication Date : April 2009
 Options
Options
Select Your Format:
 Your Price
Your Price
Price: $3,800.00
Shipping: US:  $100.00 Non-US  $100.00
 QTY: 

Print Order form to pay by check


 Related Items
Related Items
Portable Inhaler Devices - Key Tools to Differentiate Brands and Survive Generic Pressure- Stakeholder Opinions Portable Inhaler Devices - Key Tools to Differentiate Brands and Survive Generic Pressure- Stakeholder Opinions

An overview of the market for portable inhalers, looking at market shares, usefulness as tools for franchise protection and expansion. Patient and physician preferences are being analyzed as well as suitablility of molecules and inhaler types. Scope Summary of the advantages and disadvantages of the main types of portable inhaler devices Market overview highlighting CFC-free and CFC-containing devices and devices delivering branded and generic molecules, based on 2007 IMS Sales Data Overview of portable inhaler devices in non-pulmonary diseases, including inhaled insulin for the treatment of diabetes Assessment of opportunities to use portable inhaler devices as key factors in a product's commercial success throughout its lifecycle. Highlights Although a direct link between the type of device and level of disease control has never been proven, the latter is possibly indirectly influenced by the respective device's ease of use, its airflow resistance and the patient's device preferences.  (MORE)
 

Return policy: We do accept hard copy books if a reason is included. Electronic products including
CD-ROMs and PDF files are non-returnable/non-refundable due to the duplicable nature of these products.

To market your reports, contact us at 800-304-0345 or email
Helpdesk AT PharmaReports DOT com